Supernus Pharmaceuticals | SUPN - Activos Circulantes





Activos Circulantes Cambio Fecha
Abbott USD 23.5B 1.02B 2026-09
ANI Pharmaceuticals USD 902.82M 77.39M 2026-09
Aurora Cannabis CAD 393.45M 4M 2026-06
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Canopy Growth CAD 506.36M 23.1M 2026-06
Cara Therapeutics USD 25.33M 6.21M 2026-03
Corcept Therapeutics USD 533.87M 94.2M 2026-09
Eisai JPY 883.01B 121.38B 2026-06
Eli Lilly USD 65.26B 591M 2026-09
Novo Nordisk DKK 208.7B 31.38B 2026-06
Pacira USD 10.3B 9.68B 2026-09
Perrigo USD 2.4B 49.7M 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Supernus Pharmaceuticals USD 711.21M 12.28M 2026-09
United Therapeutics USD 2.88B 603.5M 2026-09
Xeris Pharmaceuticals USD 289.26M 14.51M 2026-09